ALTU-238

recombinant human growth hormone · Altus Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALTU-238, covering 2006-12-13 to 2009-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency [Phase 2]

See pricing